[{"data": {"name": "Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Jacqueline Palace", "@type": "Person"}, {"name": "Martin Duddy", "@type": "Person"}, {"name": "Michael Lawton", "@type": "Person"}, {"name": "Thomas Bregenzer", "@type": "Person"}, {"name": "Feng Zhu", "@type": "Person"}, {"name": "Mike Boggild", "@type": "Person"}, {"name": "Benjamin Piske", "@type": "Person"}, {"name": "Neil P Robertson", "@type": "Person"}, {"name": "Joel Oger", "@type": "Person"}, {"name": "Helen Tremlett", "@type": "Person"}, {"name": "Kate Tilling", "@type": "Person"}, {"name": "Yoav Ben-Shlomo", "@type": "Person"}, {"name": "Richard Lilford", "@type": "Person"}, {"name": "Charles Dobson", "@type": "Person"}], "license": "cc-by-nc", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://jnnp.bmj.com/content/jnnp/90/3/251.full.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "BMJ", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1136/jnnp-2018-318360", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CChdkFL77vWmV-CTjhqSXoW4uWp-CDFLEJmnDof9g-CRM99AEEBCra3", "propertyID": "ISCC"}], "datePublished": "2018-09-21"}, "schema": "schema.org", "mediatype": "application/ld+json"}]